CIK 0001279695
UBI UNIVERSAL BIOSENSORS INC
Insider trading from SEC Form 4. Last filing May 12, 2025.
In brief
UNIVERSAL BIOSENSORS INC (UBI) has 7 SEC Form 4 filings on file from 5 insiders, the latest filed on May 12, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
3 open-market trades have been scored at UBI. The newest: Craig E. Coleman (director and 10% owner) bought $156k of stock on May 27, 2024, filed May 28, 2024, scored 31 (weak). The largest of the 3 shown: Craig E. Coleman (director and 10% owner) bought $4.4M on May 1, 2024, scored 55 (moderate).
Last 90 days
Signals
Open-market buys and sells at UNIVERSAL BIOSENSORS INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Craig E. Coleman director, owner buy | $156k 1,421,293 shares | +2% | - | |
| 55Moderate | Craig E. Coleman director, owner buy | $4.4M 29,506,606 shares | +52% | - | |
| 27Weak | Craig E. Coleman director, owner buy | $200k 1,000,000 shares | +2% | - |
Transactions
Every row filed, 14 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 12, 2025 | Peter George Mullin CEO & Managing Director | AGrant or award Stock Option (Right to Buy)derivative | +5,000,000 | $0.00 | $0 | 5,000,000 | May 12, 2025 |
| May 12, 2025 | Peter George Mullin CEO & Managing Director | AGrant or award Stock Option (Right to Buy)derivative | +5,000,000 | $0.00 | $0 | 5,000,000 | May 12, 2025 |
| May 12, 2025 | Peter George Mullin CEO & Managing Director | AGrant or award Stock Option (Right to Buy)derivative | +5,000,000 | $0.00 | $0 | 5,000,000 | May 12, 2025 |
| May 27, 2024 | Craig E. Coleman director, owner | POpen-market purchase Common Stockindirect: By Partnership | +1,421,293 | $0.11 | $156k | 87,509,318 | May 28, 2024 |
| May 1, 2024 | Craig E. Coleman director, owner | POpen-market purchase Common Stockindirect: By Partnership | +29,289,424 | $0.15 | $4.4M | 86,088,025 | May 3, 2024 |
| May 1, 2024 | Craig E. Coleman director, owner | POpen-market purchase Common Stockindirect: By the Coleman Super Fund | +217,182 | $0.15 | $33k | 970,802 | May 3, 2024 |
| May 1, 2024 | Craig E. Coleman director, owner | POpen-market purchase Stock Option (Right to Buy)derivativeindirect: By Partnership | +29,289,424 | $0.00 | $0 | 29,289,424 | May 3, 2024 |
| May 1, 2024 | Craig E. Coleman director, owner | POpen-market purchase Stock Option (Right to Buy)derivativeindirect: By Partnership | +13,849,567 | $0.00 | $0 | 13,849,567 | May 3, 2024 |
| May 1, 2024 | Craig E. Coleman director, owner | POpen-market purchase Stock Option (Right to Buy)derivativeindirect: By the Coleman Super Fund | +217,182 | $0.00 | $0 | 217,182 | May 3, 2024 |
| Mar 25, 2024 | Craig E. Coleman director, owner | POpen-market purchase Common Stockindirect: By Partnership | +1,000,000 | $0.20 | $200k | 56,798,601 | Mar 26, 2024 |
| Mar 25, 2024 | John Stewart Sharman Chief Executive Officer | MOption exercise Common Stock | +1,364,666 | $0.20 | $273k | 1,444,666 | Mar 25, 2024 |
| Mar 25, 2024 | John Stewart Sharman Chief Executive Officer | MOption exercise Stock Option (Right to Buy)derivative | -1,364,666 | $0.00 | $0 | 0 | Mar 25, 2024 |
| Feb 27, 2024 | Salesh Balak Chief Financial Officer | JOther Stock Option (Right to Buy)derivative | -216,300 | $0.00 | $0 | 0 | Feb 28, 2024 |
| Dec 11, 2023 | Graham A McLean director | AGrant or award Common Stockindirect: Stock acquired by Milray Enterprises Pty Ltd ATF Graham McLean Family Trust | +75,000 | $0.20 | $15k | 625,000 | Dec 11, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Salesh BalakChief Financial Officer
- Craig E. Colemandirector, owner
- Graham A McLeandirector
- Peter George MullinCEO & Managing Director
- John Stewart SharmanChief Executive Officer
Questions about UBI
Answered from the filings on this page, as of the latest one.
Are insiders buying UBI?
No. In the last 90 days no insider at UNIVERSAL BIOSENSORS INC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade UBI on the open market?
Craig E. Coleman (director and 10% owner) bought $156k of UBI on May 27, 2024 and filed the Form 4 on May 28, 2024. InsiderTell scored 31 (weak).
How many insiders file Form 4 at UNIVERSAL BIOSENSORS INC?
5 people have filed a Form 4 at UNIVERSAL BIOSENSORS INC, among them Salesh Balak (Chief Financial Officer), Craig E. Coleman (director and 10% owner), Graham A McLean (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.